Bladder cancer, Transitional cell cancer
Results
Phase 2
This trial looked at gemcitabine and cisplatin chemotherapy for bladder cancer that had come back after treatment or spread to another part of the body.
Cisplatin was already being used for advanced bladder cancer, but it does cause side effects. Gemcitabine was a newer drug and appeared to cause fewer side effects.
The aims of the trial were to find out
The best dose of gemcitabine and cisplatin to use
More about the side effects
How well this combination worked for advanced bladder cancer
Recruitment start: 1 August 2001
Recruitment end: 31 December 2002
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James
University of Birmingham
Last reviewed: 12 Jan 2016
CRUK internal database number: 169